Tokio Marine Asset Management Co LTD Increases Stake in Time Warner (TWX); As Medicines Co (MDCO) Shares Declined, Three Bays Capital LP Lifted Holding by $4.18 Million

January 13, 2018 - By Adrian Mccoy

Three Bays Capital Lp increased its stake in Medicines Co (MDCO) by 7.72% based on its latest 2017Q3 regulatory filing with the SEC. Three Bays Capital Lp bought 113,000 shares as the company’s stock declined 20.30% while stock markets rallied. The institutional investor held 1.58M shares of the major pharmaceuticals company at the end of 2017Q3, valued at $58.39M, up from 1.46 million at the end of the previous reported quarter. Three Bays Capital Lp who had been investing in Medicines Co for a number of months, seems to be bullish on the $1.98B market cap company. The stock increased 0.07% or $0.02 during the last trading session, reaching $27.51. About 750,600 shares traded. The Medicines Company (NASDAQ:MDCO) has risen 16.70% since January 13, 2017 and is uptrending. It has by 0.00% the S&P500.

Tokio Marine Asset Management Co Ltd increased its stake in Time Warner Inc (TWX) by 19.6% based on its latest 2017Q3 regulatory filing with the SEC. Tokio Marine Asset Management Co Ltd bought 5,364 shares as the company’s stock rose 1.19% with the market. The institutional investor held 32,726 shares of the television services company at the end of 2017Q3, valued at $3.35 million, up from 27,362 at the end of the previous reported quarter. Tokio Marine Asset Management Co Ltd who had been investing in Time Warner Inc for a number of months, seems to be bullish on the $71.67B market cap company. The stock increased 0.17% or $0.16 during the last trading session, reaching $92.05. About 3.07M shares traded. Time Warner Inc. (NYSE:TWX) has risen 36.37% since January 13, 2017 and is uptrending. It has outperformed by 19.67% the S&P500.

Since December 7, 2017, it had 1 insider purchase, and 1 sale for $1.60 million activity. Another trade for 136,250 shares valued at $3.71M was sold by MEANWELL CLIVE.

Three Bays Capital Lp, which manages about $1.36B and $1.34 billion US Long portfolio, decreased its stake in Peabody Energy Corp New by 508,174 shares to 3.01M shares, valued at $87.35M in 2017Q3, according to the filing. It also reduced its holding in Intercontinental Exchange Inc (NYSE:ICE) by 89,100 shares in the quarter, leaving it with 969,730 shares, and cut its stake in Quintiles Ims Holdings Inc (NYSE:Q).

Investors sentiment decreased to 0.78 in 2017 Q3. Its down 0.44, from 1.22 in 2017Q2. It turned negative, as 32 investors sold MDCO shares while 64 reduced holdings. 19 funds opened positions while 56 raised stakes. 85.15 million shares or 1.36% less from 86.33 million shares in 2017Q2 were reported. Envestnet Asset Incorporated reported 2,114 shares or 0% of all its holdings. Pictet Asset Mgmt Ltd stated it has 0.04% in The Medicines Company (NASDAQ:MDCO). 3,233 were reported by Us Commercial Bank De. The New York-based Quantbot Techs LP has invested 0.02% in The Medicines Company (NASDAQ:MDCO). Parallax Volatility Advisers L P, California-based fund reported 38,043 shares. Riverhead Cap Lc holds 8,006 shares or 0.01% of its portfolio. University Of Notre Dame Du Lac accumulated 192,551 shares or 1.99% of the stock. Pointstate Cap Limited Partnership owns 0.53% invested in The Medicines Company (NASDAQ:MDCO) for 1.68M shares. Moreover, Manufacturers Life Insurance Com The has 0% invested in The Medicines Company (NASDAQ:MDCO) for 52,511 shares. Mason Street Advsrs Ltd stated it has 16,189 shares. Ameriprise Inc stated it has 0.01% in The Medicines Company (NASDAQ:MDCO). Profund Advsr Limited Liability Corporation holds 13,204 shares. 1,037 are held by Whittier Tru Of Nevada. California Public Employees Retirement, California-based fund reported 159,600 shares. Guggenheim Ltd stated it has 123,742 shares.

Among 10 analysts covering The Medicines Co (NASDAQ:MDCO), 9 have Buy rating, 0 Sell and 1 Hold. Therefore 90% are positive. The Medicines Co had 32 analyst reports since August 28, 2015 according to SRatingsIntel. Oppenheimer upgraded it to “Buy” rating and $50.0 target in Wednesday, November 29 report. On Thursday, August 10 the stock rating was maintained by Oppenheimer with “Hold”. The firm has “Hold” rating given on Wednesday, July 12 by Oppenheimer. Citigroup maintained it with “Neutral” rating and $43 target in Monday, July 17 report. As per Wednesday, August 30, the company rating was maintained by Chardan Capital Markets. The firm has “Buy” rating by H.C. Wainwright given on Monday, December 5. Cowen & Co maintained the shares of MDCO in report on Wednesday, August 9 with “Buy” rating. JP Morgan maintained The Medicines Company (NASDAQ:MDCO) on Saturday, August 29 with “Buy” rating. The company was maintained on Wednesday, November 16 by RBC Capital Markets. Jefferies maintained it with “Buy” rating and $6200 target in Monday, June 26 report.

Since December 14, 2017, it had 0 buys, and 1 insider sale for $2.11 million activity.

Tokio Marine Asset Management Co Ltd, which manages about $664.04 million US Long portfolio, decreased its stake in Merck & Co Inc (NYSE:MRK) by 5,381 shares to 72,424 shares, valued at $4.64 million in 2017Q3, according to the filing. It also reduced its holding in Medtronic Plc (NYSE:MDT) by 4,156 shares in the quarter, leaving it with 40,659 shares, and cut its stake in Terex Corp New (NYSE:TEX).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>